|
Name |
N-(2-hydroxy-6-methoxyphenyl)acetamide
|
Molecular Formula | C9H11NO3 | |
IUPAC Name* |
N-(2-hydroxy-6-methoxyphenyl)acetamide
|
|
SMILES |
CC(=O)NC1=C(C=CC=C1OC)O
|
|
InChI |
InChI=1S/C9H11NO3/c1-6(11)10-9-7(12)4-3-5-8(9)13-2/h3-5,12H,1-2H3,(H,10,11)
|
|
InChIKey |
TYPKOZGUGCPSGX-UHFFFAOYSA-N
|
|
Synonyms |
N-(2-hydroxy-6-methoxyphenyl)acetamide; SCHEMBL3208371; J3.632.320E
|
|
CAS | NA | |
PubChem CID | 12246419 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 181.19 | ALogp: | 0.7 |
HBD: | 2 | HBA: | 3 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 58.6 | Aromatic Rings: | 1 |
Heavy Atoms: | 13 | QED Weighted: | 0.684 |
Caco-2 Permeability: | -4.467 | MDCK Permeability: | 0.00001520 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.312 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.618 |
Blood-Brain-Barrier Penetration (BBB): | 0.977 | Plasma Protein Binding (PPB): | 19.14% |
Volume Distribution (VD): | 0.71 | Fu: | 71.94% |
CYP1A2-inhibitor: | 0.186 | CYP1A2-substrate: | 0.735 |
CYP2C19-inhibitor: | 0.036 | CYP2C19-substrate: | 0.711 |
CYP2C9-inhibitor: | 0.029 | CYP2C9-substrate: | 0.789 |
CYP2D6-inhibitor: | 0.021 | CYP2D6-substrate: | 0.578 |
CYP3A4-inhibitor: | 0.031 | CYP3A4-substrate: | 0.377 |
Clearance (CL): | 8.318 | Half-life (T1/2): | 0.907 |
hERG Blockers: | 0.018 | Human Hepatotoxicity (H-HT): | 0.363 |
Drug-inuced Liver Injury (DILI): | 0.464 | AMES Toxicity: | 0.313 |
Rat Oral Acute Toxicity: | 0.173 | Maximum Recommended Daily Dose: | 0.03 |
Skin Sensitization: | 0.366 | Carcinogencity: | 0.41 |
Eye Corrosion: | 0.006 | Eye Irritation: | 0.198 |
Respiratory Toxicity: | 0.082 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002891 | 0.556 | D0E9CD | 0.383 | ||||
ENC002881 | 0.510 | D0U5QK | 0.383 | ||||
ENC000033 | 0.463 | D01PJR | 0.333 | ||||
ENC001030 | 0.457 | D0GY5Z | 0.321 | ||||
ENC000168 | 0.444 | D07HBX | 0.319 | ||||
ENC001055 | 0.426 | D02XJY | 0.313 | ||||
ENC000296 | 0.426 | D02AQY | 0.304 | ||||
ENC001056 | 0.426 | D0FN7J | 0.302 | ||||
ENC000690 | 0.422 | D0U5CE | 0.297 | ||||
ENC000391 | 0.420 | D03LGG | 0.297 |